Geneva, Switzerland - 13 Dec - 16 Dec 2018 The ESMO Immuno-Oncology Congress, page-43

SuperC
I am not expecting that Dr Tabernero will be announcing anything regarding Imugene and if he does I don't think it will be anything that we don't already know, the reason I think this is that I would expect that at a presentation such as this, the presentation will have been already pre-typed into big books and handed out to paying participants so as they can keep a record of what has been presented, and that is the reason I think that Dr T won't be able to bring something really new that IMU have not yet disclosed.

So if IMU announce nothing before the presentation and then we might expect some IMU holders to feel disappointed that nothing was said at the conference (as there has been a lot of expectations that this could happen) then I really can see the price falling next week at least until the time that we hear about positive trial results at which time if they are positive the share price should rally.

fp